Articles From: Idera Pharmaceuticals Announces Cancer Immunotherapy Regimen With Intratumoral IMO-2055 Demonstrated Potent and Systemic Anti-Tumor Activity in Preclinical Models to IDT Corporation Raises Quarterly Dividend to $0.18


- IND application for Phase 1 clinical trial of IMO-9200 in healthy volunteers accepted by FDA; patient dosing on track to begin in fourth quarter CAMBRIDGE, Mass., Oct.
Sign-up for Idera Pharmaceuticals Expands Pipeline by Initiating Clinical Development of Proprietary TLR Antagonist Candidate IMO-9200 investment picks
-- Appointment brings commercial, operational and financial expertise CAMBRIDGE, Mass., Dec.
Sign-up for Idera Pharmaceuticals Names Vincent J. Milano Chief Executive Officer investment picks
- Clinical safety data for IMO-8400 support dose escalation in ongoing Phase 1/2 trials CAMBRIDGE, Mass., Dec.
Sign-up for Idera Pharmaceuticals Presents Data Supporting IMO-8400 as Novel Therapy for Genetically Defined Forms of B-Cell Lymphoma at Annual ASH Meeting investment picks
-- Enrollment achieved in first two dose cohorts of Phase 1/2 Waldenstrom's trial -- Myositis program advanced with specification of Phase 2 clinical trial plan in dermatomyositis --
Sign-up for Idera Pharmaceuticals Reports Third Quarter Financial Results and Announces Expansion of Rare Disease Development Portfolio investment picks
CAMBRIDGE, Mass., Dec.
Sign-up for Idera Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference investment picks
CAMBRIDGE, Mass., Nov.
Sign-up for Idera Pharmaceuticals to Present at the Stifel 2014 Healthcare Conference investment picks
IDEX CORPORATION (NYSE:IEX) today announced its Board of Directors has approved an additional share repurchase authorization of up to $400 million of IDEX’s outstanding common shares.
Sign-up for IDEX Corporation Announces Additional Share Repurchase Authorization investment picks
IDEX CORPORATION (NYSE:IEX) today announced that its Board of Directors has approved a regular quarterly cash dividend of $0.28 per common share.
Sign-up for IDEX Corporation Declares Regular Quarterly Cash Dividend investment picks
IDEX CORPORATION (NYSE:IEX) today announced that its Board of Directors has approved a regular quarterly cash dividend of $0.28 per common share.
Sign-up for IDEX Corporation Declares Regular Quarterly Cash Dividend investment picks
IDEX CORPORATION (NYSE: IEX) announced today that it has scheduled the broadcast of the company’s third quarter earnings conference call over the Internet on Tuesday, October 21st at 9:30 a.m. CT.
Sign-up for IDEX Corporation to Webcast Third Quarter 2014 Earnings Call investment picks
IDEX Corporation (NYSE: IEX) today announced its financial results for the three month period ended September 30, 2014.
Sign-up for IDEX Reports Third Quarter EPS of 88 Cents with Full Year EPS Guidance of $3.52 – $3.55 investment picks
- IDEXX selects UPS to support its US all-direct product distribution capability, providing IDEXX a cost effective, logistics solution for the entire continental US - IDEXX opens significantly expanded US direct customer sales center, offers free shipping and next day delivery for IDEXX direct orders; on track for 100% direct order and fulfillment capability over the course of Q4 - Strong business growth momentum continues in the US Companion Animal Group, reflected in continued strong veterinary diagnostic instrument placements in Q3 - Company announces expectation for earlier reduction of distributor inventories and reduced transitional impacts WESTBROOK, Maine , Oct.
Sign-up for IDEXX Announces Several Milestones in its US All-Direct CAG Distribution Strategy investment picks
- Delivers 11% normalized organic revenue growth and $1.05 Adjusted EPS, driven by strong growth in all business segments and regions including 12% normalized organic growth in CAG Diagnostics recurring revenues - Catalyst® and hematology instrument placements both increased over 30% in US and international markets - Transition to all-direct sales strategy in the US on track for 100% direct order and fulfillment capability in Q4 - Company announces launch of Catalyst One™, the Company's next generation chemistry analyzer, with customer shipments beginning November 3 - Strong business momentum supports increase in 2014 Adjusted EPS guidance to $3.85 to $3.90 and preliminary 2015 outlook for 13% to 14% normalized organic revenue growth and $4.38 to $4.48 Adjusted EPS WESTBROOK, Maine , Oct.
Sign-up for IDEXX Laboratories Announces Third Quarter Results investment picks
WESTBROOK, Maine , Sept.
Sign-up for IDEXX Laboratories Names Jacqueline L. Studer Corporate Vice President and General Counsel investment picks
WESTBROOK, Maine , Oct.
Sign-up for IDEXX Laboratories to Release 2014 Third Quarter Financial Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0977049001&sourceType=1 http://media3.marketwire.com/logos/20140613-IDM200.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for IDM Mining Advances Permitting of Red Mountain Gold Project investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0981725001&sourceType=1 http://media3.marketwire.com/logos/20140613-IDM200.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for IDM Mining Exploration Drilling Discovers Two New High Grade Gold Zones at the Red Mountain Gold Project investment picks
SHENZHEN, China, Sept.
Sign-up for iDreamsky and Halfbrick Release All-New Version of Fruit Ninja for Tencent investment picks
SHENZHEN, China, Oct.
Sign-up for iDreamSky Launches Card Battle Game "Sky Fall" in China investment picks
SHENZHEN, China, Oct.
Sign-up for iDreamSky Releases "Fruit Ninja for Tencent" on iOS investment picks
SHENZHEN, China, Nov.
Sign-up for iDreamSky Reports Third Quarter 2014 Unaudited Financial Results investment picks
SHENZHEN, China, Nov.
Sign-up for iDreamSky to Report Third Quarter 2014 Results on November 25, 2014 investment picks
Integrated Device Technology, Inc. ( IDT ® ) (NASDAQ: IDTI) today introduced the F0480 , an internally matched 400 to 2700 MHz broadband radio frequency (RF) variable gain amplifier (VGA) designed to simplify the design process while ensuring a more reliable implementation.
Sign-up for IDT Announces New Internally Matched Broadband RF VGA with Ultra-High Linearity investment picks
IDT Corporation (NYSE:IDT), a global provider of telecommunications and payment services, announced today that it has completed the sale of Fabrix Systems (Fabrix) to Ericsson.
Sign-up for IDT Corporation Completes Sale of Fabrix Systems investment picks
The Board of Directors of IDT Corporation (NYSE:IDT) today declared a special dividend of $0.68 per share of Class A and Class B common stock.
Sign-up for IDT Corporation Declares a Special Dividend of $0.68 per Share investment picks
The Board of Directors of IDT Corporation (NYSE:IDT) today declared a quarterly dividend of $0.17 per share of Class A and Class B common stock for the fourth quarter of its fiscal year 2014.
Sign-up for IDT Corporation Declares Fourth Quarter Dividend of $0.17 investment picks
The Board of Directors of IDT Corporation (NYSE: IDT) today declared a quarterly dividend of $0.18 per share of Class A and Class B common stock for the first quarter of its fiscal year 2015.
Sign-up for IDT Corporation Raises Quarterly Dividend to $0.18 investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Idera Pharmaceuticals Announces Cancer Immunotherapy Regimen With Intratumoral IMO-2055 Demonstrated Potent and Systemic Anti-Tumor Activity in Preclinical Models to IDT Corporation Raises Quarterly Dividend to $0.18
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent